Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

FAZ from today: Interview with a German doctor: n

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154930
(Total Views: 433)
Posted On: 11/01/2021 11:21:54 AM
Posted By: WUM
FAZ from today:
Interview with a German doctor: new guidelines, remdesivir is out!

"A new version of our Covid-19 guideline for inpatient treatment has been available since the beginning of the month. And there is new hope for the large gap in early-acting, antiviral drugs that could prevent a severe course. Previously recommended and effective is the monoclonal antibody therapy. But this is a therapy to be administered intravenously in the hospital; this is difficult for many patients in the first week of illness because they are not yet in the clinic and if the symptoms are mild at the beginning of the disease, they do not see any need to do so. Antibody therapy has shown success in studies, but in practice it is difficult to reach patients with it. We had placed a lot of hope in remdesivir, which should no longer be given according to the new guideline. Molnupiravir works similarly to remdesivir, but there is No published study yet, but a press release from the manufacturer.The advantage is that this Medi kament can be taken as a tablet. Therefore, a GP who diagnoses an infection and sees some risk may prescribe it. Molnupiravir could then be taken directly, and preliminary data suggests that it will cut hospital admissions in half. But in contrast to vaccination with this drug, there is reason to believe that the germ cells could be damaged - that is why the study participants were obliged to use contraception. So this will not be a miracle drug with no side effects, but a component in our therapy regime. It is not a substitute for vaccination, but it can make the disease less severe."...


(1)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us